C Frere
Overview
Explore the profile of C Frere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charles S, Fatrara T, Bouriche T, Bonifay A, Lecompte T, Dignat-George F, et al.
Thromb Res
. 2025 Jan;
247:109256.
PMID: 39823789
Background: Candidate biomarkers to improve venous thromboembolism (VTE) risk prediction in patients with newly diagnosed multiple myeloma (MM) undergoing anti-myeloma therapy include tissue factor-bearing microvesicles (MV-TF), procoagulant phospholipids (procoag-PPL), and...
2.
Laporte S, Benhamou Y, Bertoletti L, Frere C, Hanon O, Couturaud F, et al.
Rev Med Interne
. 2024 May;
45(6):366-381.
PMID: 38789323
Although all patients with cancer-associated thrombosis (CAT) have a high morbidity and mortality risk, certain groups of patients are particularly vulnerable. This may expose the patient to an increased risk...
3.
Mahe I, Frere C, Pernod G, Sanchez O, Baih A
Rev Med Interne
. 2024 May;
45(5):300-311.
PMID: 38763817
This article addresses the management of venous thromboembolism in patients with malignant brain tumours, including both primary and secondary (metastatic) tumours. The available data on patients on venous thromboembolism recurrence...
4.
Frere C, Farge D, Douketis J, Connors J
J Med Vasc
. 2022 Sep;
47(3):113-115.
PMID: 36055679
No abstract available.
5.
Frere C, Crichi B, Rueda-Camino J, Cajfinger F, Spiess N, Janus N, et al.
J Med Vasc
. 2022 Jun;
47(2):56-64.
PMID: 35691664
Background: Real word data on the efficacy and safety of long-term use of tinzaparin for the treatment of cancer-associated thrombosis (CAT) are scarce. Methods: We performed a post-hoc analysis of...
6.
Sebuhyan M, Crichi B, Deville L, Le Maignan C, Bonnet C, Marjanovic Z, et al.
J Med Vasc
. 2021 Dec;
46(5-6):215-223.
PMID: 34862015
Introduction: Treatment of cancer-associated thrombosis (CAT) requires specific approaches, although it is well codified in most cases. Current national and international (International Initiative on Cancer and Thrombosis, ITAC) Clinical Practice...
7.
Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, et al.
J Med Vasc
. 2020 Nov;
45(6):334-343.
PMID: 33248536
Introduction: The Coronavirus disease-2019 outbreak (COVID-19) has been declared a pandemic by the World Health Organization. Studies report both a severe inflammatory syndrome and a procoagulant state in severe COVID-19...
8.
Hekimian G, Frere C, Collet J
Ann Cardiol Angeiol (Paris)
. 2020 Oct;
69(6):360-364.
PMID: 33092785
Extracorporeal membrane oxygenation (ECMO) is mainly used as a rescue therapy in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). More rarely, COVID-19 can be complicated by hemodynamic failure...
9.
Sakka M, Connors J, Hekimian G, Martin-Toutain I, Crichi B, Colmegna I, et al.
J Med Vasc
. 2020 Sep;
45(5):268-274.
PMID: 32862984
Background: Several observational studies have reported elevated baseline D-dimer levels in patients hospitalized for moderate to severe coronavirus disease 2019 (COVID-19). These elevated baseline D-dimer levels have been associated with...
10.
Pineton De Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, et al.
J Intern Med
. 2020 Aug;
289(3):427-429.
PMID: 32772406
No abstract available.